Abeona Therapeutics Inc expected to post a loss of 61 cents a share - Earnings Preview

Abeona Therapeutics

09/05/2023 12:57

* Abeona Therapeutics Inc  ABEO.OQ   ABEO.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 11
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Abeona Therapeutics
Inc
is for a loss of 61 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Abeona
Therapeutics Inc is $20​, above​ its last closing price
of $3.13. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022              -0.75      1.53      Beat    304
 Sep. 30 2022  -1.75       -1.75      -1.48     Beat    15.3
 Jun. 30 2022  -1.94       -1.87      -2.08     Missed  -10.9​
 Mar. 31 2022  -2.00       -2.37      -3.50     Missed  -47.4
 ​​Dec.        -4.67       -3.67      -3.50     Beat    4.5
 31 2021                                                
 Sep. 30 2021  -4.09       -4.06      -4.00     Beat    1.5​
 Jun. 30 2021  -4.12       -4.12      -4.00     Beat    3
 Mar. 31 2021  -4.79       -4.67      -4.25     Beat    8.9
 This summary was machine generated May 9 at 11:56 GMT.  All
figures in US dollars  unless otherwise stated